CTOs on the Move

Cellanyx

www.cellanyx.com

 
Cellanyx has developed proprietary live tumor cell phenotypic biomarker tests to improve cancer risk-stratification and allow informed clinical decision making. The Companys unique approach provides quantitative and actionable information based on analysis of thousands of live tumor cells. The Companys tests employ a microfluidic platform combined with machine vision and machine learning approaches to analyze phenotypic morphological, biochemical and biophysical markers. Cellanyx has demonstrated initial clinical proof-of-concept with its lead phenotypic test in prostate cancer. The initial clinical proof-of-concept study was conducted to demonstrate improved risk stratification in men with low and intermediate Gleason grade (6 and 7) disease and ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.cellanyx.com
  • 100 Cummings Center Suite 451C
    Beverly, MA USA 01915
  • Phone: 978.473.7883

Executives

Name Title Contact Details
Ashok Chander
Chief Technology Officer Profile

Similar Companies

General Healthcare Resources

General Healthcare Resources is a Plymouth Meeting, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Alliance Life Sciences Consulting Group

Alliance Life Sciences Consulting Group is a Bridgewater, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lakeshore Biomaterials

Lakeshore Biomaterials is a Birmingham, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CareOregon Advantage

CareOregon Advantage is a Portland, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Eyecarrot

Eyecarrot’s goal is to power a global, data-driven, expert therapeutic network to transform how human Oculomotor Sensory performance is diagnosed, exercised and enhanced. The company is building Binovi, a universal, collaborative care platform that integrates software, hardware, data and the expert knowledge and insights of vision care professionals to help patients on a global scale.